Abstract | OBJECTIVES: METHODS: RESULTS: At baseline, serum sIL-2R (Rs = 0.532, p < .001) and IgG4 (Rs = 0.545, p < .001) levels showed significant correlation to the number of organs involved. During follow-up period (median, 70 months; range, 7-195 months), 40 patients were treated with corticosteroids. Receiver operating characteristic (ROC) analysis showed that baseline sIL-2R levels most accurately predicted patients requiring glucocorticoid treatment (area under the ROC curve, 0.807). Among the 46 patients who improved, sIL-2R and IgG4 levels decreased in 42 and 41 patients, respectively. Among them, serum sIL-2R levels decreased to a normal range in 42 patients (91%), whereas IgG4 levels normalized in 19 (41%). CONCLUSION: The serum sIL-2R level is a potential biomarker for IgG4-RD that may reflect the number of involved organs and may predict patients requiring glucocorticoid treatment.
|
Authors | Tomohiro Handa, Shoko Matsui, Hajime Yoshifuji, Yuzo Kodama, Hiroshi Yamamoto, Seijiro Minamoto, Yuko Waseda, Yasuharu Sato, Keishi Kubo, Tsuneyo Mimori, Tsutomu Chiba, Toyohiro Hirai, Michiaki Mishima |
Journal | Modern rheumatology
(Mod Rheumatol)
Vol. 28
Issue 5
Pg. 838-844
(Sep 2018)
ISSN: 1439-7609 [Electronic] England |
PMID | 29251035
(Publication Type: Journal Article)
|
Chemical References |
- Biomarkers
- Immunoglobulin G
- Receptors, Interleukin-2
|
Topics |
- Adult
- Autoimmune Diseases
(blood)
- Biomarkers
(blood)
- Female
- Humans
- Immunoglobulin G
(blood)
- Male
- Middle Aged
- Receptors, Interleukin-2
(blood)
|